Pulmonary Lobectomy After COVID-19.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 32987024.
- Also identified by DOI 10.1016/j.athoracsur.2020.08.004 and PMC identifier 7518286.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Concomitant coronavirus disease 19 (COVID-19) is a major risk factor for complications in any type of surgical procedure, especially in thoracic surgery, were the primary organ involved, the lung, is manipulated to perform parenchymal resection. However, it is not clear whether previous infection from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) may lead to increased morbidity and mortality for subsequent procedures once radiologic resolution is achieved. We report a young patient with lung cancer who successfully underwent a right upper lobectomy for primary adenocarcinoma by video-assisted thoracoscopic surgery with no complication in the early postoperative phase.
Medical subject headings
- COVID-19
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- Pneumonectomy
- SARS-CoV-2
- Thoracic Surgery, Video-Assisted